These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23764827)

  • 1. Selective accumulation of aluminum in cerebral arteries in Alzheimer's disease (AD).
    Bhattacharjee S; Zhao Y; Hill JM; Culicchia F; Kruck TP; Percy ME; Pogue AI; Walton JR; Lukiw WJ
    J Inorg Biochem; 2013 Sep; 126():35-7. PubMed ID: 23764827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomolar aluminum induces expression of the inflammatory systemic biomarker C-reactive protein (CRP) in human brain microvessel endothelial cells (hBMECs).
    Alexandrov PN; Kruck TP; Lukiw WJ
    J Inorg Biochem; 2015 Nov; 152():210-3. PubMed ID: 26265215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher aluminum concentration in Alzheimer's disease after Box-Cox data transformation.
    Rusina R; Matěj R; Kašparová L; Kukal J; Urban P
    Neurotox Res; 2011 Nov; 20(4):329-33. PubMed ID: 21567285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum in hippocampal neurons from humans with Alzheimer's disease.
    Walton JR
    Neurotoxicology; 2006 May; 27(3):385-94. PubMed ID: 16458972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype.
    Chow N; Bell RD; Deane R; Streb JW; Chen J; Brooks A; Van Nostrand W; Miano JM; Zlokovic BV
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):823-8. PubMed ID: 17215356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Aspects of Aluminum Exposure in Alzheimer's Disease Development.
    Kandimalla R; Vallamkondu J; Corgiat EB; Gill KD
    Brain Pathol; 2016 Mar; 26(2):139-54. PubMed ID: 26494454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser microprobe analysis of brain aluminum in Alzheimer's disease.
    Lovell MA; Ehmann WD; Markesbery WR
    Ann Neurol; 1993 Jan; 33(1):36-42. PubMed ID: 8257483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reexamination of aluminum in Alzheimer's disease: analysis by energy dispersive X-ray microprobe and flameless atomic absorption spectrophotometry.
    Jacobs RW; Duong T; Jones RE; Trapp GA; Scheibel AB
    Can J Neurol Sci; 1989 Nov; 16(4 Suppl):498-503. PubMed ID: 2804812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer's Disease.
    Yumoto S; Kakimi S; Ishikawa A
    J Alzheimers Dis; 2018; 65(4):1267-1281. PubMed ID: 30149443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons.
    Perl DP; Brody AR
    Science; 1980 Apr; 208(4441):297-9. PubMed ID: 7367858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum-induced oxidative events in cell lines: glioma are more responsive than neuroblastoma.
    Campbell A; Prasad KN; Bondy SC
    Free Radic Biol Med; 1999 May; 26(9-10):1166-71. PubMed ID: 10381187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in Alzheimer's disease hippocampus: a topographical study.
    Cruz-Sánchez FF; Gironès X; Ortega A; Alameda F; Lafuente JV
    J Neurol Sci; 2010 Dec; 299(1-2):163-7. PubMed ID: 20863531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum and Alzheimer's disease.
    McLachlan DR
    Neurobiol Aging; 1986; 7(6):525-32. PubMed ID: 3550508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum involvement in the progression of Alzheimer's disease.
    Walton JR
    J Alzheimers Dis; 2013; 35(1):7-43. PubMed ID: 23380995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells.
    Alexandrov PN; Zhao Y; Pogue AI; Tarr MA; Kruck TP; Percy ME; Cui JG; Lukiw WJ
    J Alzheimers Dis; 2005 Nov; 8(2):117-27; discussion 209-15. PubMed ID: 16308480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum and Alzheimer's disease: a new look.
    Miu AC; Benga O
    J Alzheimers Dis; 2006 Nov; 10(2-3):179-201. PubMed ID: 17119287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum toxicity to the brain.
    Krishnan SS; McLachlan DR; Krishnan B; Fenton SS; Harrison JE
    Sci Total Environ; 1988 Apr; 71(1):59-64. PubMed ID: 3358118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
    Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease.
    Savaskan E; Olivieri G; Brydon L; Jockers R; Kräuchi K; Wirz-Justice A; Müller-Spahn F
    Neurosci Lett; 2001 Jul; 308(1):9-12. PubMed ID: 11445273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.